Consensus Demant A/S Wiener Boerse

Equities

End-of-day quote Wiener Boerse Other stock markets 18:00:00 2024-06-26 EDT			5-day change	1st Jan Change
40.86 ^EUR	-1.49%		0.00%	+2.97%

06-26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

d52a.I0gJ8WMbp-rjN72FLiFwoVXS4gR2SknCo4JYCqGd_iE.TwBBx1Us8oK8BM7PW0Uq1S-QjWgPOwuD6ccXRvH8sGZzfmaYKn6XgaRE_A~eb61b2e57ab17378ec3e97d7a537e67b

DEMANT : Q1 sales miss; organic growth guidance unchanged	05-06
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	02-06
DEMANT : Sales broadly in-line; guidance narrowed	11-07
Chinese headwinds could be more severe than expected	23-09-22
DEMANT : Better-than-expected Q2 + a guidance upgrade	23-08-22
DEMANT : Better-than-expected Q2 + a guidance upgrade	23-08-16
DEMANT : New product launches + a rebound in hearing aids are encouraging	23-05-03
DEMANT : Strong Q1 + guidance upgrade	23-04-25
DEMANT : Strong Q1 + guidance upgrade	23-04-18
DEMANT : Strong Q4 + promising takeaways	23-04-05
DEMANT : Strong Q4 + promising takeaways	23-02-07
DEMANT : Soft Q3 + consecutive guidance downgrade	22-11-02
DEMANT : Soft Q2 + guidance downgrade	22-08-17
DEMANT : In line Q1, full year guidance reiterated	22-05-05
DEMANT : Hearing Healthcare recovery continues; capitalise the entry opportunity	22-02-09
DEMANT : Marginal guidance upgrade won’t trigger a change in stance	21-11-02
DEMANT : 2021 CMD: ambitious targets unveiled	21-09-29
DEMANT : As communications slows, hearing healthcare takes the lead; FY21 outlook upgraded	21-08-13
ANALYST RECOMMENDATIONS : American Express, HSBC, CyrusOne, Microsoft, Vodafone...	21-06-18
DEMANT : Better-than-expected operational performance ytd; FY21 targets raised	21-05-04
DEMANT : Pent-up demand visible in H2 20; ambitious guidance for FY21	21-02-10